ANAB
AnaptysBio Inc.
Company Overview
| Mkt Cap | $981.85M | Price | $36.58 |
| Volume | 229.87K | Change | +0.30% |
| P/E Ratio | -6.8 | Open | $36.40 |
| Revenue | $91.3M | Prev Close | $36.47 |
| Net Income | $-145.2M | 52W Range | $12.21 - $38.39 |
| Div Yield | N/A | Target | $62.09 |
| Overall | 55 | Value | 40 |
| Quality | 52 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyAnaptysBio Inc. (ANAB) is a leading Healthcare company in the Biotechnology industry, currently trading at $36.58 with a market capitalization of $981.85 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 52.
Today's trading session shows ANAB with a volume of 230K shares. The stock opened down 0.19% from yesterday's close of $36.47. Current analyst estimates project earnings of $-3.83 per share for this year, with next year targeting $-4.81.
ANAB demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ANAB include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 69.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANAB | $36.58 | +0.3% | 229.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |